UBS lowered the firm’s price target on Exponent (EXPO) to $76 from $84 and keeps a Neutral rating on the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXPO:
- Exponent’s Q2 2025 Earnings: Steady Revenue Amid Challenges
- Exponent Declares Quarterly Dividend Amid Revenue Growth
- Exponent reports Q2 EPS (52c), consensus 52c
- Exponent sees Q3 revenue before reimbursements up mid-single digits
- Exponent sees FY25 revenue before reimbursements up in the low single digits